A multi-center randomized proof-of-concept clinical trial applying [¹?F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples